Suppr超能文献

银屑病筛查中的眼部表现(OcMaPS)问卷:揭示银屑病眼部受累误诊情况的有用工具。

Ocular Manifestations in Psoriasis Screening (OcMaPS) Questionnaire: A Useful Tool to Reveal Misdiagnosed Ocular Involvement in Psoriasis.

作者信息

Ruggiero Angelo, Fabbrocini Gabriella, Cacciapuoti Sara, Cinelli Eleonora, Gallo Lucia, Megna Matteo

机构信息

Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Via Pansini 5, 80131 Napoli, Italy.

出版信息

J Clin Med. 2021 Mar 3;10(5):1031. doi: 10.3390/jcm10051031.

Abstract

Psoriasis is an immune-mediated, chronic inflammatory disease, which mainly affects the skin, although it has systemic pathological effects. Comorbidities of psoriasis include ocular disorders, which are often nonspecific or mildly symptomatic. The aim of this study was to show the importance of ocular-disease screening in psoriatic patients using the Ocular Manifestations in Psoriasis Screening (OcMaPS) questionnaire. Patients suffering from moderate-to-severe psoriasis referring at our outpatient-clinic were consecutively enrolled. Each patient was asked to complete a screening questionnaire (OcMaPS). Patients reporting ocular symptoms were referred for an ophthalmological examination. A total of 372 patients were enrolled in the study. Ocular symptoms were detected in 39 patients (10.5%), and 37 patients were referred to ophthalmological examination which confirmed the presence of ocular manifestation in 30 patients. There were three cases (10%) of uveitis, 14 (46.6%) of dry eye and 13 (43.3%) of cataract, in progress or already treated with surgery. In the remaining seven patients, no ocular manifestations were found. Ocular manifestations in psoriatic patients are not rare. It is important to be aware of ocular symptoms in psoriatic patients, screening patients (with a consultation or OcMaPS questionnaire), which leads to earlier diagnosis and treatment.

摘要

银屑病是一种免疫介导的慢性炎症性疾病,主要影响皮肤,不过也有全身病理效应。银屑病的合并症包括眼部疾病,这些疾病往往是非特异性的或症状轻微。本研究的目的是通过银屑病眼部表现筛查(OcMaPS)问卷来表明对银屑病患者进行眼部疾病筛查的重要性。连续纳入在我们门诊就诊的中重度银屑病患者。每位患者都被要求完成一份筛查问卷(OcMaPS)。报告有眼部症状的患者被转介进行眼科检查。共有372名患者纳入该研究。39名患者(10.5%)检测到眼部症状,37名患者被转介进行眼科检查,其中30名患者经检查确诊有眼部表现。有3例(10%)葡萄膜炎、14例(46.6%)干眼症和13例(43.3%)白内障,有的正在发病,有的已经接受了手术治疗。其余7名患者未发现眼部表现。银屑病患者的眼部表现并不罕见。了解银屑病患者的眼部症状很重要,应对患者进行筛查(通过咨询或OcMaPS问卷),这有助于早期诊断和治疗。

相似文献

2
Ocular findings in patients with psoriasis: is it related to the side effects of treatment or to psoriasis itself? A case-control study.
J Dermatolog Treat. 2020 Feb;31(1):27-32. doi: 10.1080/09546634.2019.1577947. Epub 2019 Mar 1.
3
Ocular manifestations in moderate-to-severe psoriasis in India: A prospective observational study.
Indian J Ophthalmol. 2022 Sep;70(9):3328-3332. doi: 10.4103/ijo.IJO_551_22.
4
Psoriasis and Psoriatic Arthritis-Related Uveitis: Different Ophthalmological Manifestations and Ocular Inflammation Features.
Semin Ophthalmol. 2017;32(6):715-720. doi: 10.3109/08820538.2016.1170161. Epub 2016 Jul 15.
5
Ocular surface disease in psoriatic patients in a developing country.
Int Ophthalmol. 2021 Jun;41(6):2139-2147. doi: 10.1007/s10792-021-01771-8. Epub 2021 Mar 31.
6
An observational study on ocular manifestations in patients of psoriasis in a tertiary care hospital in western India.
Med J Armed Forces India. 2022 Sep;78(Suppl 1):S186-S193. doi: 10.1016/j.mjafi.2020.12.019. Epub 2021 Mar 26.
7
Ocular psoriasis.
J Am Acad Dermatol. 2011 Dec;65(6):1202-12. doi: 10.1016/j.jaad.2010.10.032. Epub 2011 May 6.
8
Psoriasis beyond the skin surface: a pilot study on the ocular involvement.
Int Ophthalmol. 2015 Jun;35(3):331-40. doi: 10.1007/s10792-014-9950-8. Epub 2014 May 6.
9
Identifying and Treating Ocular Manifestations in Psoriasis.
Am J Clin Dermatol. 2022 Jan;23(1):51-60. doi: 10.1007/s40257-021-00648-x. Epub 2021 Nov 3.
10
Tear film and ocular surface assessment in psoriasis.
Br J Ophthalmol. 2018 Mar;102(3):302-308. doi: 10.1136/bjophthalmol-2017-310307. Epub 2017 Jul 8.

引用本文的文献

1
Bidirectional association between uveitis and psoriasis: a systematic review and meta-analysis.
Clin Exp Med. 2025 May 15;25(1):161. doi: 10.1007/s10238-025-01693-0.
3
Elevated Serum Levels of Osteopontin in Patients with Psoriasis: Is It Associated with Ocular Comorbidities?
Dermatol Pract Concept. 2024 Oct 30;14(4):e2024226. doi: 10.5826/dpc.1404a226.
4
Mapping the psoriasis research landscape: A comprehensive bibliometric analysis from 2012-2023.
Int J Immunopathol Pharmacol. 2024 Jan-Dec;38:3946320241290341. doi: 10.1177/03946320241290341.
5
A Comprehensive Review of Ocular Manifestations in Systemic Diseases.
Cureus. 2024 Jul 29;16(7):e65693. doi: 10.7759/cureus.65693. eCollection 2024 Jul.
6
Management Strategies for Pediatric Moderate-to-Severe Plaque Psoriasis: Spotlight on Biologics.
Pediatric Health Med Ther. 2023 Nov 14;14:435-451. doi: 10.2147/PHMT.S389108. eCollection 2023.
8
Injections Site Reactions and Biologics for Psoriasis: A Questionnaire Based Real Life Study.
Clin Cosmet Investig Dermatol. 2023 Mar 2;16:553-564. doi: 10.2147/CCID.S400679. eCollection 2023.
9
Ocular manifestations of psoriasis: An inflammatory disease beyond the skin.
J Gen Fam Med. 2022 Aug 26;24(1):45-49. doi: 10.1002/jgf2.576. eCollection 2023 Jan.
10
Anti-IL23 biologic therapies in the treatment of psoriasis: real-world experience versus clinical trials data.
Immunol Res. 2023 Jun;71(3):328-355. doi: 10.1007/s12026-022-09356-y. Epub 2023 Jan 4.

本文引用的文献

2
The Incidence and Prevalence of Uveitis in Psoriasis: A Systematic Review and Meta-Analysis.
J Cutan Med Surg. 2020 Nov/Dec;24(6):601-607. doi: 10.1177/1203475420952420. Epub 2020 Aug 31.
4
Guselkumab in moderate to severe psoriasis in routine clinical care: an Italian 44-week real-life experience.
J Dermatolog Treat. 2022 Mar;33(2):1074-1078. doi: 10.1080/09546634.2020.1800577. Epub 2020 Aug 4.
6
A review of ocular adverse events of biological anti-TNF drugs.
J Ophthalmic Inflamm Infect. 2020 Apr 27;10(1):11. doi: 10.1186/s12348-020-00202-6.
8
Ocular changes in patients with psoriasis.
Clin Dermatol. 2019 Nov-Dec;37(6):663-667. doi: 10.1016/j.clindermatol.2019.07.029. Epub 2019 Jul 31.
9
Psoriasis and uveitis: links and risks.
Psoriasis (Auckl). 2019 Aug 28;9:91-96. doi: 10.2147/PTT.S179182. eCollection 2019.
10
Psoriasis Pathogenesis and Treatment.
Int J Mol Sci. 2019 Mar 23;20(6):1475. doi: 10.3390/ijms20061475.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验